NCT06659237View on ClinicalTrials.gov

Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
MicrobiomePancreatic Neoplasms16s RRNA
Interventions
DIAGNOSTIC_TEST

16s rRNA or shotgun metagenomics

16s rRNA or shotgun metagenomics on oral and fecal samples

Trial Locations (1)

Unknown

Department of General Surgery, Peking Union Medical College Hospital (PUMCH), Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT06659237 - Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients | Biotech Hunter | Biotech Hunter